LillyDirect Now Connects Patients to Zepbound and Foundayo Prescriptions
Eli Lilly's direct-to-patient platform LillyDirect has expanded to include prescriptions for Zepbound and the newly launched Foundayo, offering a streamlined path from consultation to delivery.
Eli Lilly has expanded its direct-to-patient platform, LillyDirect, to cover prescriptions for its weight-loss medication Zepbound and the newly introduced Foundayo. The service is designed to simplify how patients access these treatments by consolidating the process into a single online channel, from medical consultation to home delivery.
What the Platform Offers
LillyDirect functions as a telehealth and pharmacy hub that connects users with licensed healthcare providers who can evaluate eligibility and, when appropriate, issue prescriptions. Once approved, medications are shipped directly to the patient's door through partnered pharmacies. The platform aims to reduce common barriers such as long wait times, insurance complexity, and limited availability of in-person prescribers familiar with GLP-1 and related therapies.
Zepbound and Foundayo Availability
Zepbound, approved for chronic weight management, has been available through LillyDirect for some time. The addition of Foundayo marks a notable expansion. Foundayo is positioned as part of Lilly's broader effort to broaden access to obesity and metabolic health treatments. According to the company, including both drugs on the same platform gives patients and providers a more unified prescribing experience.
How Patients Can Get Started
To use the service, patients typically complete the following steps:
- Visit the LillyDirect website and create an account.
- Complete a health questionnaire covering medical history and current medications.
- Meet virtually with a platform-affiliated provider to determine eligibility.
- If approved, receive the prescription through a partner pharmacy with delivery included.
Industry observers note that the integration reflects a broader shift toward consumer-friendly digital health models. For more context on how nutrition and pharmaceutical trends have evolved, see this look at shifting nutrition advice and the rise of protein-focused dieting. Patients are advised to confirm coverage and out-of-pocket costs with their insurer before beginning treatment.